References
- Monagle P, Chan AKC, Goldenberg NA, et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e737S–e801S. doi:https://doi.org/10.1378/chest.11-2308.
- Monagle P, Cuello CA, Augustine C, et al. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018;2(22):3292–3316. doi:https://doi.org/10.1182/bloodadvances.2018024786.
- Raffini L. Thrombolysis for intravascular thrombosis in neonates and children. Curr Opin Pediatr. 2009;21(1):9–14. doi:https://doi.org/10.1097/MOP.0b013e32831ef537.
- Kahn SR, Solymoss S, Lamping DL, Abenhaim L. Long-term outcomes after deep vein thrombosis: postphlebitic syndrome and quality of life. J Gen Intern Med. 2000;15(6):425–429. doi:https://doi.org/10.1046/j.1525-1497.2000.06419.x.
- van Korlaar IM, Vossen CY, Rosendaal FR, et al. The impact of venous thrombosis on quality of life. Thromb Res. 2004;114(1):11–18. doi:https://doi.org/10.1016/j.thromres.2004.04.007.
- van Korlaar I, Vossen C, Rosendaal F, Cameron L, Bovill E, Kaptein A. Quality of life in venous disease. Thromb Haemost. 2003;90(1):27–35.
- Lubberts B, Paulino PN, Kabrhel C, Kuter DJ, DiGiovanni CW. What is the effect of venous thromboembolism and related complications on patient reported health-related quality of life? A meta-analysis. Thromb Haemost. 2016;116(3):417–431.
- Kahn SR, Ducruet T, Lamping DL, et al. Prospective evaluation of health-related quality of life in patients with deep venous thrombosis. Arch Intern Med. 2005;165(10):1173–1178. doi:https://doi.org/10.1001/archinte.165.10.1173.
- Raffini L, Huang YS, Witmer C, Feudtner C. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics. 2009;124(4):1001–1008. doi:https://doi.org/10.1542/peds.2009-0768.
- Vedantham S, Goldhaber SZ, Julian JA, et al. Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis. N Engl J Med. 2017;377(23):2240–2252. doi:https://doi.org/10.1056/NEJMoa1615066.
- Enden T, Haig Y, Kløw NE, et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet (London, England). 2012;379(9810):31–38. doi:https://doi.org/10.1016/S0140-6736(11)61753-4.
- Notten P, Ten Cate-Hoek AJ, Arnoldussen C, et al. Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial. Lancet Haematol. 2020;7(1):e40–e49. doi:https://doi.org/10.1016/S2352-3026(19)30209-1.
- Dandoy CE, Kukreja KU, Gruppo RA, Patel MN, Tarango C. Outcomes in children with deep vein thrombosis managed with percutaneous endovascular thrombolysis. Pediatr Radiol. 2015;45(5):719–726. doi:https://doi.org/10.1007/s00247-014-3209-4.
- Gaballah M, Shi J, Kukreja K, et al. Endovascular thrombolysis in the management of iliofemoral thrombosis in children: a multi-institutional experience. J Vasc Interven Radiol JVIR. 2016;27(4):524–530. doi:https://doi.org/10.1016/j.jvir.2015.12.753.
- Goldenberg NA, Branchford B, Wang M, Ray C, Jr., Durham JD, Manco-Johnson MJ. Percutaneous mechanical and pharmacomechanical thrombolysis for occlusive deep vein thrombosis of the proximal limb in adolescent subjects: findings from an institution-based prospective inception cohort study of pediatric venous thromboembolism. J Vasc Interven Radiol JVIR. 2011;22(2):121–132. doi:https://doi.org/10.1016/j.jvir.2010.10.013.
- Goldenberg NA, Durham JD, Knapp-Clevenger R, Manco-Johnson MJ. A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children. Blood. 2007;110(1):45–53. doi:https://doi.org/10.1182/blood-2006-12-061234.
- Kukreja KU, Lungren MP, Patel MN, et al. Endovascular venous thrombolysis in children younger than 24 months. J Vasc Interven Radiol JVIR. 2014;25(8):1158–1164. doi:https://doi.org/10.1016/j.jvir.2014.04.003.
- Male C, Lensing AWA, Palumbo JS, et al. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. Lancet Haematol. 2019;Jan;7(1):e18–e27. doi:https://doi.org/10.1016/S2352-3026(19)30219-4. Epub 2019 Nov 5.
- Monagle P, Lensing AWA, Thelen K, et al. Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies. Lancet Haematol. 2019;6(10):e500–e509. doi:https://doi.org/10.1016/S2352-3026(19)30161-9.
- Mitchell LG, Goldenberg NA, Male C, Kenet G, Monagle P, Nowak-Göttl U. Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children. J Thromb Haemost. 2011;9(9):1856–1858. doi:https://doi.org/10.1111/j.1538-7836.2011.04433.x.
- Tian S, Sinclair N, Shah S. A case report of intravascular hemolysis and heme pigment-induced nephropathy following AngioJet thrombectomy for thrombosed DIPS shunt. Can J Kidney Health Dis. 2020;7:2054358120979233. doi:https://doi.org/10.1177/2054358120979233.
- Vesely TM, Williams D, Weiss M, et al. Comparison of the angiojet rheolytic catheter to surgical thrombectomy for the treatment of thrombosed hemodialysis grafts. Peripheral AngioJet Clinical Trial. J Vasc Interv Radiol. 1999;10(9):1195–1205. doi:https://doi.org/10.1016/S1051-0443(99)70220-4.
- Zhu J, Ni CF, Dai ZY, Yao LZ, Li WH. A case-controlled study on AngioJet rheolytic thrombectomy and catheter-directed thrombolysis in the treatment of acute lower extremity deep venous thrombosis. Vascular. 2020;28(2):177–182. doi:https://doi.org/10.1177/1708538119877322.
- Jeyabalan G, Saba S, Baril DT, Makaroun MS, Chaer RA. Bradyarrhythmias during rheolytic pharmacomechanical thrombectomy for deep vein thrombosis. J Endovasc Ther. 2010;17(3):416–422. doi:https://doi.org/10.1583/10-3087.1.
- Dwarka D, Schwartz SA, Smyth SH, O'Brien MJ. Bradyarrhythmias during use of the AngioJet system. J Vasc Interv Radiol. 2006;17(10):1693–1695. doi:https://doi.org/10.1097/01.RVI.0000236629.26319.65.
- Goldenberg NA, Donadini MP, Kahn SR, et al. Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors. Haematologica. 2010;95(11):1952–1959. doi:https://doi.org/10.3324/haematol.2010.026989.
- Kahn SR, Comerota AJ, Cushman M, et al. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2014;130(18):1636–1661. doi:https://doi.org/10.1161/CIR.0000000000000130.
- Albisetti M. Thrombolytic therapy in children. Thromb Res. 2006;118(1):95–105. doi:https://doi.org/10.1016/j.thromres.2004.12.018.
- Darbari DS, Desai D, Arnaldez F, et al. Safety and efficacy of catheter directed thrombolysis in children with deep venous thrombosis. Br J Haematol. 2012;159(3):376–378. doi:https://doi.org/10.1111/bjh.12025.
- Taha MA, Busuttil A, Bootun R, Davies AH. A systematic review of paediatric deep venous thrombolysis. Phlebology. 2019;34(3):179–190. doi:https://doi.org/10.1177/0268355518778660.
- Avila ML, Pullenayegum E, Williams S, Yue N, Krol P, Brandão LR. Postthrombotic syndrome and other outcomes of lower extremity deep vein thrombosis in children. Blood. 2016;128(14):1862–1869. doi:https://doi.org/10.1182/blood-2016-03-704585.
- Loja MN, Brunson A, Li CS, et al. Racial disparities in outcomes of endovascular procedures for peripheral arterial disease: an evaluation of California hospitals, 2005-2009. Ann Vasc Surg. 2015;29(5):950–959. doi:https://doi.org/10.1016/j.avsg.2015.01.006.
- Lemaire A, Cook C, Tackett S, Mendes DM, Shortell CK. The impact of race and insurance type on the outcome of endovascular abdominal aortic aneurysm (AAA) repair. J Vasc Surg. 2008;47(6):1172–1180. doi:https://doi.org/10.1016/j.jvs.2008.01.033.
- White RH, Dager WE, Zhou H, Murin S. Racial and gender differences in the incidence of recurrent venous thromboembolism. Thromb Haemost. 2006;96(3):267–273.
- Vandenbroucke JP, Rosing J, Bloemenkamp KW, et al. Oral contraceptives and the risk of venous thrombosis. N Engl J Med. 2001;344(20):1527–1535. doi:https://doi.org/10.1056/NEJM200105173442007.
- Kujovich JL. Hormones and pregnancy: thromboembolic risks for women. Br J Haematol. 2004;126(4):443–454. doi:https://doi.org/10.1111/j.1365-2141.2004.05041.x.
- Tarango C, Manco-Johnson MJ. Pediatric thrombolysis: a practical approach. Front Pediatr. 2017;5:260. doi:https://doi.org/10.3389/fped.2017.00260.
- Fleming GA, Khan M, Janssen D, Doyle T. Angiojet rheolytic thrombectomy in infants following cardiac surgery. Catheter Cardiovasc Interv. 2010;76(2):233–240. doi:https://doi.org/10.1002/ccd.22544.
- Sarper N, Zengin E, Aylan S, Gelen, Babaoglu K. PB2437 thrombolytic therapy in pediatric patients; outcome and complications of tissue plasminogen activator. HemaSphere. 2019;3(S1):1079–1080. doi:https://doi.org/10.1097/01.HS9.0000568208.78420.b6.
- Manco-Johnson MJ, Grabowski EF, Hellgreen M, et al. Recommendations for tPA thrombolysis in children. On behalf of the Scientific Subcommittee on Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thromb Haemost. 2002;88(07):157–158. doi:https://doi.org/10.1055/s-0037-1613170.
- Ansah DA, Patel KN, Montegna L, Nicholson GT, Ehrlich AC, Petit CJ. Tissue plasminogen activator use in children: bleeding complications and thrombus resolution. The J Pediat. 2016;171:67–72. e61-62. doi:https://doi.org/10.1016/j.jpeds.2015.11.020.
- Leaker M, Massicotte MP, Brooker LA, Andrew M. Thrombolytic therapy in pediatric patients: a comprehensive review of the literature. Thromb Haemost. 1996;76(2):132–134.
- Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood. 1987;70(1):165–172.
- Andrew M, Brooker L, Leaker M, Paes B, Weitz J. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration. Thromb Haemost. 1992;68(3):325–330.